Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combination

This publication has 14 references indexed in Scilit:

• 13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix
  JNCI Journal of the National Cancer Institute, 1992
• 13-cis-Retinoic Acid and Interferon -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin
  JNCI Journal of the National Cancer Institute, 1992
• Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation
  The Journal of Steroid Biochemistry and Molecular Biology, 1991
• Acitretin Decreases Tumor Cell-Induced Angiogenesis
  Skin Pharmacology and Physiology, 1991
• Development of angiogenesis inhibitors for clinical applications
  Trends in Pharmacological Sciences, 1990
• What Is the Evidence That Tumors Are Angiogenesis Dependent?
  JNCI Journal of the National Cancer Institute, 1990
• Expression of the angiogenic phenotype by a subpopulation of keratinocytes derived from 7,12-dimethylbenz[a]anthracene-initiated hamster buccal pouch epithelium
  Carcinogenesis: Integrative Cancer Research, 1988
• Inhibition of tumour-induced angiogenesis by systemically administered protamine sulphate
  International Journal of Cancer, 1984
• Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.
  The Journal of Experimental Medicine, 1975
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971